期刊文献+

人血清微量sCR1蛋白双抗体夹心ELISA试剂盒的评价与应用

Evaluation and application of double antibody sandwich ELISA kit for micro-quantitative soluble complement receptor 1 protein in human serum
下载PDF
导出
摘要 目的对研制的人血清微量sCR1蛋白双抗体夹心ELISA试剂盒的重复性、稳定性进行评价,并了解其实际应用效果。方法选取中、晚期肝硬化患者50例和健康体检者50例分别作为肝病组和正常对照组,以鼠抗人CD35单克隆抗体、兔抗人sCR1多克隆抗体和辣根过氧化物酶标记的山羊抗兔IgG为包被抗体、夹心抗体和检测抗体,以纯化后的重组人sCR1蛋白为标准品,建立人血清微量sCR1蛋白双抗体夹心ELISA试剂盒,进行试剂盒重复性和稳定性检验,并应用该试剂盒检测两组血清sCR1蛋白水平。结果双抗体夹心ELISA法检测人血清微量sCR1蛋白的线性范围是15.60~250.00ng/mL;血清sCR1蛋白水平对吸光度值的回归方程为Y=112.10 X2+18.21 X+1.694(r2=0.998);重复性检测中,高、低水平标准品检测值的批内相对标准偏差(RSD)分别为6.20%、7.40%,批间RSD分别为6.70%和7.90%;试剂盒稳定性检测中,RSD均不大于0.01;肝病组血清sCR1表达水平显著高于正常对照组(P<0.01)。结论人血清微量sCR1蛋白双抗体夹心ELISA试剂盒线性范围广、重复性好、易于保存,适合于临床和科研检测工作。 Objective To evaluate the repeatability and stability of double antibody sandwich ELISA kit for micro-quantitative soluble complement receptor 1(sCR1)in human serum and to understand its practical application effect.Methods 50 patients with middle and advanced liver cirrhosis and 50 individuals undergoing physical examination served as the liver disease group and normal control group respectively.The mouse anti-human CD35 monoclone antibody,rabbit anti-human sCR1 polyclonal antibody and goat anti-rabbit IgG labeled by horseradish peroxidase served as the envelope antibody,sandwich antibody and detection antiboby.The purified recombinant human sCR1 protein served as the standard substance.The human serum micro-quantitative double antibody sandwich CR1 ELISA kit was established.Then the repeatability and stability tests were performed.Then the sCR1 protein level of two group of serum was detected by this kit.Results The linear range of double antibody sandwich ELISA for detecting human serum micro-quantitative sCR1 protein was 15.60-250.00 ng/mL;the regression equation of sCR1 protein concentration to absorbance value was Y=112.10 X^2+18.21 X+1.694(r^2=0.998);in the repeatability test,the intra-batch relative standard deviation(RSD)in high and low concentrations of standard substance detection value was 6.20% and 7.40% respectively,the inter-batch RSD was 6.70%and 7.90%respectively;in the stability test,RSD was not more than 0.01;the serum sCR1 expression level in the liver disease group was significantly higher than that in the normal control group(P0.01).Conclusion The human serum double antibody sandwich ELISA kit for detecting human sCR1 has wide linear range,good repeatability,is easy to be stored and suitable for clinical and scientific research detection work.
机构地区 解放军第 解放军第
出处 《国际检验医学杂志》 CAS 2017年第21期2952-2954,共3页 International Journal of Laboratory Medicine
基金 河南省重点科技攻关项目(102102310161)
关键词 可溶性补体受体1型 双抗体夹心法 酶联免疫吸附试验 soluble complement receptor type 1 double antibody sandwich ELISA
  • 相关文献

参考文献11

二级参考文献76

  • 1罗雪,汪正清.人sCR1结合C3b结构域基因的克隆及在大肠杆菌中高效表达[J].第三军医大学学报,2005,27(15):1551-1554. 被引量:7
  • 2曹文飞,罗卜.AFP酶免疫测定的HOOK效应[J].中国免疫学杂志,1995,11(2):99-100. 被引量:12
  • 3谭兵,张德纯,汪正清.重组人可溶性补体受体1型SCR15-18片段表达纯化及生物活性鉴定[J].第三军医大学学报,2007,29(10):892-895. 被引量:6
  • 4Costa C, Zhao L,. Shen Y, et al. Role of complement component C5 in cerebral ischemia/reperfusion injury[J]. Brain Res, 2006, 1100(1) : 142 - 151.
  • 5Mocco J, Mack WJ, Ducruet AF, et al. Complement component C3 mediates inflammatory injury following focal cerebral ischemia [ J ]. Cite Res, 2006, 99 (2) : 209 - 217.
  • 6You Z, Yang J, Takahashi K, et al. Reduced tissue damage and improved recovery of motor function after traumatic brain injury in mice deficient in complement component CA [J]. Cerebral Blood Flow Metab, 2007, 27(12): 1954 - 1964.
  • 7Arumugam TV, Tang SC, Lathia JD, et al. Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement - mediated neuronal cell death [ J ]. Proc Natl Acad Sei USA, 2007, 104 (35): 14104-14109.
  • 8Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J ]. Stroke, 1989, 20 (1): 84-91.
  • 9Cowell RM, Plane JM, Silverstein FS. Complement activation contributes to hypoxic - ischemic brain injury in neonatal rats [ J ]. J Neurosci, 2003, 23 (28) : 9459 - 9462.
  • 10Thurman JM, Holers VM. The central role of the alternative complement pathway in human disease [ J ]. J Immunol, 2006, 176(3): 1305-1310.

共引文献446

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部